Corrigendum to “Atorvastatin induced hepatic oxidative stress and apoptotic damagevia MAPKs, mitochondria, calpain and caspase12 dependent pathways” [Food Chem. Toxicol. 83 (2015) 36–47, (S0278691515001817), (10.1016/j.fct.2015.05.016)];Atorvastatin induced hepatic oxidative stress and apoptotic damage via MAPKs, mitochondria, calpain and caspase12 dependent pathways

Food and Chemical Toxicology

Volumn 83, Issue , 2015, Pages 36-47

  Pal, Sankhadeep ^a   Ghosh, Manoranjan ^a   Ghosh, Shatadal ^a   Bhattacharyya, Sudip ^a   Sil, Parames C ^a  

^a BOSE INSTITUTE   (India)

Author keywords

Apoptosis; Atorvastatin; Oxidative stress; ROS

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ATORVASTATIN; CALPAIN; CASPASE 12; CASPASE 9; CYTOCHROME C; GLUTATHIONE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; BIOLOGICAL MARKER; CASP12 PROTEIN, MOUSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN SECRETION; SIGNAL TRANSDUCTION; AGONISTS; ANIMAL; BLOOD; CALCIUM SIGNALING; DOSE RESPONSE; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; ENDOPLASMIC RETICULUM STRESS; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; RANDOMIZATION; SURVIVAL ANALYSIS;

ANIMALS; APOPTOSIS; ATORVASTATIN CALCIUM; BIOMARKERS; CALCIUM SIGNALING; CALPAIN; CASPASE 12; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; ENDOPLASMIC RETICULUM STRESS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LIVER; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MITOCHONDRIA, LIVER; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; SURVIVAL ANALYSIS;

EID: 84944064050     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2023.114301     Document Type: Erratum

References (53)

1. Santodomingo-Garzon, T., Cunha, T., M., Verri Jr., W.A., Valerio, D., Parada, C., A., Poole, S., Ferreira, S., H., Cunha, F., Q., 2006. Atorvastatin inhibits inflammatory hypernociception. Br. J. Pharmacol 149, 14-22.
2. Aktas, O., Waiczies, S., Smorodchenko, A., Dorr, J., Seeger, B., Prozorovski, T., 2003. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197, 725-733.
3. Balaban, R., S., Nemoto, S., Finkel, T., 2005. Mitochondria, oxidants, and aging. Cell 120, 483-495.
4. Barsante, M., M., Roffe, E., Yokoro, C., M., Tafuri, W., L., Souza, D., G., Pinho, V., 2005. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. Eur. J. Pharmacol. 516, 282-289.
5. Bays, H., 2006. Statin safety: an overview and assessment of the datae2005. Am. J. Cardiol. 97, 6C-26C.
6. Bouitbir, J., Charles, A., L., Laguna, A., E., Kindo, M., Daussin, F., Auwerx, J., Piquard, F., Geny, B., Zoll, J., 2012. Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. Euro. Heart J. 33, 1397-1407.
7. Bradford, M., M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
8. Bras, M., Queenan, B., Susin, S., A., 2005. Programmed cell death via mitochondria: different modes of dying. Biochem. 70, 231-239.
9. Bruckert, E., Hayem, G., Dejager, S., Yau, C., Begaud, B., 2005. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patientsethe PRIMO study. Cardiovasc. Drugs Ther. 19, 403-414.
10. Buettner, C., Davis, R., B., Leveille, S., G., Mittleman, M., A., Mukamal, K., J., 2008. Prevalence of musculoskeletal pain and statin use. J. Gen. Intern. Med. 23, 1182-1186.
11. Chandrasekaran, V., Hsu, D., Liu, M., 2009. The protective effect of sesamol against mitochondrial oxidative stress and hepatic injury in acetaminophen-overdosed rats. Shock 32, 89-93.
12. Das, J., Sil, P.C., 2012. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats. Amino Acids 43, 1509-1523.
13. Das, J., Ghosh, J., Manna, P., Sil, P.C., 2008. Taurine provides antioxidant defense against NaF-induced cytotoxicity in murine hepatocytes. Pathophysiology 15, 181-190.
14. Das, J., Ghosh, J., Manna, P., Sinha, M., Sil, P.C., 2009a. Taurine protects rat testes against NaAsO2-induced oxidative stress and apoptosis via mitochondrial dependent and independent pathways. Toxicol. Lett. 187, 201-210.
15. Das, J., Ghosh, J., Manna, P., Sinha, M., Sil, P.C., 2009b. Arsenic-induced oxidative cerebral disorders: protection by taurine. Drug Chem. Toxicol. 32, 93-102.
16. Das, J., Ghosh, J., Manna, P., Sil, P.C., 2012. Taurine protects rat testes against doxorubicin-induced oxidative stress as well as p53, Fas and caspase 12-mediated apoptosis. Amino Acids 42, 1839-1855.
17. Dolphin, D., 1989. Glutathione: Chemical, Biochemical and Medical Aspects. Wiley, New York (NY) (Part A and B).
18. Draeger, A., Monastyrskaya, K., Mohaupt, M., Hoppeler, H., Savolainen, H., Allemann, C., Babiychuk, E., B., 2006. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. J. Pathol. 210, 94-102.
19. Endo, A., 2004. The discovery and development of HMG-CoA reductase inhibitors1992. Atheroscler. Suppl. 5, 67-80.
20. Eruslanov, E., Kusmartsev, S., Armstrong, D., 2010. Advanced Protocols in Oxidative Stress II, Methods in Molecular Biology. Humana Press, A Part of Springer Science + Business Media, LLC, p. 594.
21. Esterbauer, H., Cheeseman, K.H., 1990. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186, 407-421.
22. Ferro, D., Parrotto, S., Basili, S., Alessandri, C., Violi, F., 2000. Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia. J. Am. Coll. Cardiol. 36, 427-431.
23. Festa, M., Capasso, A., D'Acunto, C., W., 2011. Xanthohumol induces apoptosis in human malignant glioblastoma cells by increasing reactive oxygen species and activating MAPK pathways. J. Nat. Pro. 74, 2505-2513.
24. Ghosh, J., Das, J., Manna, P., Sil, P.C., 2010. Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection. Free Rad. Biol. Med. 48, 535-553.
25. Ghosh, M., Pal, S., Sil, P.C., 2014. Taurine attenuates nano copper induced oxidative hepatic damage via mitochondria dependent and NF-κB/TNF-α mediated pathway. Toxicol. Res. 3, 474-486.
26. Ghosh, S., Bhattacharyya, S., Rashid, K., Sil, P.C., 2015. Curcumin protects rat liver from streptozotocin-induced diabetic pathophysiology by counteracting reactive oxygen species and inhibiting the activation of p53 and MAPKs mediated stress response pathways. Toxicol. Rep. 2, 365-376.
27. Hengartner, M., O., 2000. The biochemistry of apoptosis. Nature 407, 770-776.
28. Jacobson, T.A., 2008. Toward "pain-free" statin prescribing: clinical algorithm for diagnosis and management of myalgia. Mayo. Clin. Proc. 83, 687-700.
29. Jones, D., P., 2002. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348, 93-112.
30. Keeble, J., A., Gilmore, A., P., 2007. Apoptosis commitmentetranslating survival signals into decisions on mitochondria. Cell. Res. 17, 976-984.
31. Launay-Vacher, V., Izzedine, H., Deray, G., 2005. Statins' dosage in patients with renal failure and cyclosporine drugedrug interactions in transplant recipient patients. Int. J. Cardiol. 101, 9-17.
32. LeBel, C., P., Bondy, S., C., 1990. Sensitive and rapid quantitation of oxygen reactive species formation in rat synaptosomes. Neurochem. Int. 17, 435-440.
33. Manna, P., Ghosh, M., Ghosh, J., Das, J., Sil, P.C., 2012. Contribution of nano-copper particles to in vivo liver dysfunction and cellular damage: role of IkBα/NF-κB, MAPKs and mitochondrial signal. Nanotoxicology 6, 1-21.
34. Miller Jr., W., H., Schipper, H., M., Lee, J., S., Singer, J., Waxman, S., 2004. Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903.
35. Mingatto, F., E., Rodrigues, T., Pigoso, A., A., Uyemura, S., A., Curti, C., 2003. The critical role of mitochondrial energetic impairment in the toxicity of nimesulide to hepatocytes. J. Pharmacol. Exp. Ther. 303, 601-607.
36. Morishima, N., Nakanishi, K., Takenouchi, H., Shibata, T., Yasuhiko, Y., 2002. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277, 34287-34294.
37. Nakagawa, T., Yuan, J., 2000. Cross-talk between two cysteine protease families: activation of Caspase-12 by Calpain in apoptosis. J. Cell. Biol. 150, 887-894.
38. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B., A., Yuan, J., 2000. Caspase-12 mediates endoplasmicreticulum-specific apoptosis and cytotoxicity by amyloid-b. Nature 403, 98-103.
39. Pal, S., Sarkar, A., Pal, P.B., Sil, P.C., 2015. Protective effect of arjunolic acid against atorvastatin induced hepatic and renal pathophysiology via MAPK, mitochondria and ER dependent pathways. Biochimie 112, 20-34.
40. Pearson, G., Robinson, F., Gibson, T.B., 2001. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22, 153-183.
41. Pelicano, H., Feng, L., Zhou, Y., Carew, J.S., Hileman, E., O., Plunkett, W., 2003. Inhibition of mitochondrial respiration: a novel strategy to enhance drug-induced apoptosis in human leukemia cells by a reactive oxygen species-mediated mechanism. J. Biol. Chem. 278, 37832-37839.
42. Qi, X., F., Zheng, L., Lee, K., J., Kim, D., H., Kim, C., S., Cai1, D.Q., Wu, Z., Qin, J., W., Yu, Y., H., Kim, S., K., 2013. HMG-CoA reductase inhibitors induce apoptosis of lymphoma cells by promoting ROS generation and regulating Akt, Erk and p38 signals via suppression of mevalonate pathway. Cell. Death Dis. 4, e518.
43. Rashid, K., Sil, P.C., 2015a. Curcumin ameliorates testicular damage in diabetic rats by suppressing cellular stress mediated mitochondria and endoplasmic reticulum dependent apoptotic death. Biochim. Biophys. Acta Molecular Basis Dis. 1852, 70-82.
44. Rashid, K., Sil, P.C., 2015b. Curcumin enhances recovery of pancreatic islets from cellular stress induced inflammation and apoptosis in diabetic rats. Toxicol. Appl. Pharmacol. 282, 297-310.
45. Roy, A., Manna, P., Sil, P.C., 2009. Prophylactic role of taurine on arsenic mediated oxidative renal dysfunction via MAPKs/NF-kappaB and mitochondria dependent pathways. Free Radic. Res. 43, 995-1007.
46. Sakaeda, T., Kadoyama, K., Okun, Y., 2011. Statin-associated muscular and renal adverse events: data mining of the public version of the FDA adverse event reporting system. PLoS One 6, e28124.
47. Sinha, M., Manna, P., Sil, P.C., 2007. A 43 kD protein from the herb, Cajanus indicus L, plays protective role against sodium fluoride induced oxidative stress in mice erythrocytes. Pathophysiology 14, 47-54.
48. Solheim, S., Seljeflot, I., Arnesen, H., Eritsland, J., Eikvar, L., 2001. Reduced levels of TNF alpha in hypercholesterolemic individuals after treatment with pravastatin for 8 weeks. Atherosclerosis 157, 411-415.
49. Thompson, P., D., Clarkson, P., Karas, R., H., 2003. Statin-associated myopathy. J. Am. Med. Assoc. 289, 1681-1690.
50. Tobert, J., A., 2003. Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors. Nat. Rev. Drug Discov. 2, 517-526.
51. Topol, E., J., 2004. Intensive statin therapyea sea change in cardiovascular prevention. N. Engl. J. Med. 350, 1562-1564.
52. Uchida, K., Stadtman, E.R., 1993. Covalent attachment of 4-hydroxynonenal to glyceraldehydes-3-phosphate dehydrogenase. J. Biol. Chem. 268, 6388-6393.
53. Wang, C., Y., Liu, P.Y., Liao, J.K., 2008. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol. Med. 14, 37-44.